{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:57:09Z","timestamp":1787907429793,"version":"build-2784847793"},"reference-count":81,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T00:00:00Z","timestamp":1722729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Bia\u0142ystok","award":["B.SUB.24.348"],"award-info":[{"award-number":["B.SUB.24.348"]}]},{"name":"Medical University of Bia\u0142ystok","award":["B.SUB.24.350"],"award-info":[{"award-number":["B.SUB.24.350"]}]},{"name":"Medical University of Bia\u0142ystok","award":["II4.0\/2021\/UD\/03"],"award-info":[{"award-number":["II4.0\/2021\/UD\/03"]}]},{"name":"Innovation Incubator 4.0","award":["B.SUB.24.348"],"award-info":[{"award-number":["B.SUB.24.348"]}]},{"name":"Innovation Incubator 4.0","award":["B.SUB.24.350"],"award-info":[{"award-number":["B.SUB.24.350"]}]},{"name":"Innovation Incubator 4.0","award":["II4.0\/2021\/UD\/03"],"award-info":[{"award-number":["II4.0\/2021\/UD\/03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The objective of the conducted research was to design 2 mm orodispersible minitablets of pediatric doses of hydrocortisone (0.5 mg; 1.0 mg) with desirable pharmaceutical properties and eliminate the sensation of a bitter taste using preparation of solid dispersion by ball mill. Hydrocortisone was selected as the model substance, as it is widely utilized in the pediatric population. ODMTs were prepared by compression (preceded by granulation) in a traditional single-punch tablet machine and evaluated using pharmacopoeial tests, DSC, and FTIR analysis. The methods used to evaluate the effectiveness of the taste-masking effect included in vivo participation of healthy volunteers, in vitro drug dissolution and utilization of an analytical device\u2014\u201celectronic tongue\u201d. The research employed a preclinical animal model to preliminary investigate the bioequivalence of the designed drug dosage form in comparison to reference products. The study confirmed the possibility of manufacturing good-quality hydrocortisone ODMTs with a taste-masking effect owing to the incorporation of a solid dispersion in the tablet mass.<\/jats:p>","DOI":"10.3390\/pharmaceutics16081041","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T07:37:30Z","timestamp":1722843450000},"page":"1041","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Utilization of the Drug\u2013Polymer Solid Dispersion Obtained by Ball Milling as a Taste Masking Method in the Development of Orodispersible Minitablets with Hydrocortisone in Pediatric Doses"],"prefix":"10.3390","volume":"16","author":[{"given":"Monika","family":"Trofimiuk","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Medical University of Bialystok, Mickiewicza 2a, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-7016","authenticated-orcid":false,"given":"Katarzyna","family":"Olechno","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Trofimiuk","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Bialystok, Waszyngtona 15a, 15-274 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5025-4864","authenticated-orcid":false,"given":"Anna","family":"Czajkowska-Ko\u015bnik","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Ciosek-Skibi\u0144ska","sequence":"additional","affiliation":[{"name":"Chair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"G\u0142owacz","sequence":"additional","affiliation":[{"name":"Chair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2364-4429","authenticated-orcid":false,"given":"Joanna","family":"Lenik","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Institute of Chemical Sciences, Faculty of Chemistry, Maria Curie Sklodowska University, Maria Curie-Sklodowska Square 3, 20-031 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2331-1779","authenticated-orcid":false,"given":"Anna","family":"Basa","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, University of Bia\u0142ystok, Cio\u0142kowskiego 1K, 15-245 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halina","family":"Car","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Bialystok, Waszyngtona 15a, 15-274 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1013-610X","authenticated-orcid":false,"given":"Katarzyna","family":"Winnicka","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/17425247.2018.1472571","article-title":"Patient centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness","volume":"15","author":"Stegemann","year":"2018","journal-title":"Expert. Opin. Drug Deliv."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/bcp.14388","article-title":"Challenges and opportunities to include patient-centric product design in industrial medicines development to improve therapeutic goals","volume":"86","author":"Timpe","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Menditto, E., Orlando, V., De Rosa, G., Minghetti, P., Musazzi, U.M., Cahir, C., Kurczewska-Michalak, M., Kardas, P., Costa, E., and Lobo, J.M.S. (2020). Patient centric pharmaceutical drug product design\u2014The impact on medication adherence. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010044"},{"key":"ref_4","unstructured":"International Council for Harmonisation (2024, May 19). Pharmaceutical Development Q8 (R2). Available online: https:\/\/database.ich.org\/sites\/default\/files\/Q8_R2_Guideline.pdf."},{"key":"ref_5","first-page":"26","article-title":"Drug formulations: Standards and novel strategies for drug administration in pediatrics","volume":"S10","author":"Thabet","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Malkawi, W.A., AlRafayah, E., AlHazabreh, M., AbuLaila, S., and Al-Ghananeem, A.M. (2022). Formulation challenges and strategies to develop pediatric dosage forms. Children, 9.","DOI":"10.3390\/children9040488"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zuccari, G., Alfei, S., Marimpietri, D., Iurilli, V., Barabino, P., and Marchitto, L. (2022). Mini-Tablets: A valid strategy to combine efficacy and safety in pediatrics. Pharmaceuticals, 15.","DOI":"10.3390\/ph15010108"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, F., Clapham, D., Krysiak, K., Batchelor, H., Field, P., Caivano, G., Pertile, M., Nunn, A., and Tuleu, C. (2019). Making medicines baby size: The challenges in bridging the formulation gap in neonatal medicine. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112688"},{"key":"ref_9","unstructured":"WHO (2012). Development of paediatric medicines: Points to consider in formulation. WHO Tech. Rep. Series., 970, 1\u201322. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/medicines\/norms-and-standards\/guidelines\/trs970\/annex5trs-70.pdf?sfvrsn=699cdb68_8&download=true."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/cpt.2336","article-title":"Benefit-risk assessment of off-label drug use in children: The Bravo framework","volume":"110","author":"Mooij","year":"2021","journal-title":"Clin. Pharm. Therap."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Petkova, V., Georgieva, D., Dimitrov, M., and Nikolova, I. (2023). Off-label prescribing in pediatric population\u2014Literature review for 2012\u20132022. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15122652"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"bvaa091","DOI":"10.1210\/jendso\/bvaa091","article-title":"Manipulation of hydrocortisone tablets leads to iatrogenic cushing syndrome in a 6-year-old girl with CAH","volume":"4","author":"Fleissner","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.5731\/pdajpst.2015.006411","article-title":"Dose uniformity of scored and unscored tablets: Application of the FDA tablet scoring guidance for industry","volume":"70","author":"Ciavarella","year":"2016","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1016\/j.xphs.2020.08.021","article-title":"The development of minitablets for a pediatric dosage form for a combination therapy","volume":"109","author":"Zhang","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejpb.2020.06.012","article-title":"Age-appropriate solid oral formulations for pediatric applications with a focus on multiparticulates and minitablets: Summary of September 2019 EuPFI workshop","volume":"153","author":"Harrisa","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Alessandrini, E., Brako, F., Scarpa, M., Lupo, M., Bonifazi, D., Pignataro, V., Cavallo, M., Cullufe, O., Enache, C., and Nafria, B. (2021). Children\u2019s preferences for oral dosage forms and their involvement in formulation research via EPTRI (European Paediatric Translational Research Infrastructure). Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13050730"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.xphs.2024.02.016","article-title":"Current state of minitablet product design: A review","volume":"113","author":"Singaraju","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Page, S., Rode, T., Breitkreutz, J., and Wagner-Hattler, L. (2024). Minitablets current use and future opportunities\u2014An APV course on manufacturing, packaging, characterization and use of minitablets. Eur. J. Pharm.Biopharm., 199.","DOI":"10.1016\/j.ejpb.2024.114294"},{"key":"ref_19","unstructured":"WHO (2020). Innovative Delivery Systems for Paediatric Medicines: Technology Landscape, World Health Organization. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/348336\/9789240008182-eng.pdf?sequence=1."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drudis.2017.10.003","article-title":"Orodispersible dosage forms: Biopharmaceutical improvements and regulatory requirements","volume":"23","author":"Cilurzo","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2020.08.014","article-title":"Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound\u2014A promising starting point for future PUMA applications","volume":"156","author":"Freerks","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1208\/s12249-016-0584-1","article-title":"European Paediatric Formulation Initiative (EuPFI)","volume":"18","author":"Salunke","year":"2017","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1080\/10837450.2019.1615090","article-title":"Orally disintegrating tablets and orally disintegrating mini tablets\u2014Novel dosage forms for pediatric use","volume":"24","author":"Comoglu","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/1567201817666200508093442","article-title":"New orodispersible mini tablets of enalapril maleate by direct compression for pediatric patients","volume":"17","author":"Ortega","year":"2020","journal-title":"CDD"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejpb.2021.06.007","article-title":"Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial","volume":"166","author":"Meissner","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"103154","DOI":"10.1016\/j.jddst.2022.103154","article-title":"Comparative acceptability of mini-tablets, fine granules, and liquid formulations in young children: An exploratory randomised crossover study","volume":"70","author":"Miyazaki","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Mitsui, N., Hida, N., Kamiya, T., Yamazaki, T., Miyazaki, K., Saito, K., Saito, J., Yamatani, A., Ishikawa, Y., and Nakamura, H. (2022). Swallowability of minitablets among children aged 6\u201323 months: An exploratory, randomized crossover study. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010198"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hu, J., Fitaihi, R., Abukhamees, S., and Abdelhakim, H. (2023). Formulation and characterisation of carbamazepine orodispersible 3D-printed mini-tablets for Paediatric Use. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010250"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Alalaiwe, A., Alsenaidy, M.A., Almalki, Z.S., and Fayed, M.H. (2023). Development and optimization of sildenafil orodispersible mini-tablets (ODMTs) for treatment of pediatric pulmonary hypertension using response surface methodology. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030923"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1208\/s12249-021-02185-6","article-title":"Implementing the design of experiments (DoE) concept into the development phase of orodispersible minitablets (ODMTs) containing melatonin","volume":"23","author":"Hejduk","year":"2022","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Protopapa, C.H., Siamidi, A., Kolipala, S.S., Jungueira, L.A., Douroumis, D., and Vlachou, M. (2024). In vitro profile of hydrocortisone release from three-dimensionally printed paediatric mini-tablets. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16030385"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"123131","DOI":"10.1016\/j.ijpharm.2023.123131","article-title":"Development of 3D printed mini-waffle shapes containing hydrocortisone for children\u2019s personalized medicines","volume":"642","author":"Protopapa","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wasilewska, K., Skibi\u0144ska-Ciosek, P., Lenik, J., Srcic, S., Basa, A., and Winnicka, K. (2020). Utilization of ethylcellulose microparticles with rupatadine fumarate in designing orodispersible minitablets with taste masking effect. Materials, 13.","DOI":"10.3390\/ma13122715"},{"key":"ref_34","first-page":"CD012517","article-title":"Glucocorticoid replacement regimens in the treatment of 21-hydroxylase deficiency congenital adrenal hyperplasia","volume":"3","author":"Ng","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jim-2019-000999","article-title":"Emergency management of adrenal insufficiency in children: Advocating for treatment options in outpatient and field settings","volume":"68","author":"Miller","year":"2019","journal-title":"J. Investig. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.beem.2018.05.010","article-title":"Primary adrenal insufficiency in children: Diagnosis and management","volume":"32","author":"Kirkgoz","year":"2018","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_37","first-page":"1","article-title":"A Prospective study of children sged 0\u20138 Years with CAH and adrenal insufficiency treated with hydrocortisone granules","volume":"20","author":"Neumann","year":"2020","journal-title":"JCEM"},{"key":"ref_38","unstructured":"(2024, May 19). Hydrocortisone Dosage Regimen. Available online: https:\/\/www.medscape.co.uk\/drug\/hydrocortisone-oral-standard-release-69049-69049."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/archdischild-2016-311535.17","article-title":"Comparison of hydrocortisone 10 mg tablets: Tablet hardness optimised for adult use has negative consequences for paediatric use","volume":"101","author":"Saimbi","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2018.04.054","article-title":"How close is the dose? Manipulation of 10 mg hydrocortisone tablets to provide appropriate doses to children","volume":"545","author":"Watson","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e000198","DOI":"10.1136\/bmjpo-2017-000198","article-title":"Content uniformity of quartered hydrocortisone tablets in comparison with mini-tablets for paediatric dosing","volume":"2","author":"Peak","year":"2018","journal-title":"BMJPO"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1530\/EJE-17-0248","article-title":"Quality of compounded hydrocortisone capsules used in the treatment of children","volume":"177","author":"Neumann","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_43","unstructured":"(2024, May 19). Alkindi\u00ae Sprinkle. Available online: https:\/\/ec.europa.eu\/health\/documents\/community-register\/2021\/20210519151899\/anx_151899_pl.pdf."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2147\/PPA.S164406","article-title":"A spoonful of sugar helps the medicine go down? A review of strategies for making pills easier to swallow","volume":"12","author":"Forough","year":"2018","journal-title":"Patient Prefer. Adherence"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2014.01.036","article-title":"Taste-masking assessment of solid oral dosage forms\u2014A critical review","volume":"465","author":"Pein","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1567201814666171013145958","article-title":"Taste masking approaches for medicines","volume":"15","author":"Faisal","year":"2018","journal-title":"Curr. Drug Deliv."},{"key":"ref_47","first-page":"1895","article-title":"Review on: Taste masking approaches and evaluation of taste masking","volume":"4","author":"Thoke","year":"2012","journal-title":"Int. J. Pharm. Sci."},{"key":"ref_48","first-page":"352","article-title":"Taste masking of steroids for oral formulations","volume":"20","author":"Ahmed","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"ref_49","first-page":"175","article-title":"Preparation and characterization of azithromycin\u2014Aerosil 200 solid dispersions with enhanced physical stability","volume":"486","author":"Li","year":"2015","journal-title":"Pharm. Nanotechnol."},{"key":"ref_50","first-page":"1","article-title":"Aqueous and pH dependent coacervation method for taste masking of paracetamol via amorphous solid dispersion formation","volume":"11","author":"Alsirawan","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_51","first-page":"1998","article-title":"Development a taste-masked acetaminophen solid dispersions using Eudragit\u00ae E100 polymer by solvent evaporation technique","volume":"27","author":"Shahoud","year":"2023","journal-title":"J. Res. Pharm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"120279","DOI":"10.1016\/j.ijpharm.2021.120279","article-title":"Quaternary enteric solid dispersion prepared by hot-melt extrusion to mask the bitter taste and enhance drug stability","volume":"597","author":"Zhao","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajps.2014.12.006","article-title":"Overview of milling techniques for improving the solubility of poorly water-soluble drugs","volume":"10","author":"Loh","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.1039\/c3cs35455e","article-title":"Process engineering with planetary ball mills","volume":"42","author":"Burmeister","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jconrel.2020.05.045","article-title":"Hypromellose\u2014A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery","volume":"324","author":"Vllasaliu","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_56","unstructured":"Rowe, R.C., Sheskey, P.J., and Quinn, M.E. (2009). Handbook of Pharmaceutical Excipients, Pharmaceutical Press. [6th ed.]."},{"key":"ref_57","unstructured":"(2024, May 19). FDA, HPMC, Available online: https:\/\/www.fda.gov\/search?s=hypromellose&sort_bef_combine=rel_DESC."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e021961","DOI":"10.1136\/bmjopen-2018-021961","article-title":"Evaluation of patient-reported outcome measurements as a reliable tool to measure acceptability of the taste of paediatric medicines in an inpatient paediatric population","volume":"8","author":"Mistry","year":"2018","journal-title":"BMJ Open"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.drudis.2016.05.014","article-title":"Non-human tools for the evaluation of bitter taste in the design and development of medicines: A systematic review","volume":"21","author":"Soto","year":"2016","journal-title":"Drug Discov. Today"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"\u0141aba\u0144ska, M., Ciosek-Skibi\u0144ska, P., and Wr\u00f3blewski, W. (2019). Critical evaluation of laboratory potentiometric electronic tongues for pharmaceutical analysis\u2014An overview. Sensors, 19.","DOI":"10.3390\/s19245376"},{"key":"ref_61","unstructured":"(2024, May 19). Hydrocortisone-SF. Available online: https:\/\/www.sunfarm.pl\/library\/2020\/09\/09\/159964896157.pdf."},{"key":"ref_62","unstructured":"Council of Europe (2023). European Pharmacopoeia, Council of Europe. [11th ed.]."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejps.2016.10.012","article-title":"Formulation of polysaccharide-based nanoparticles for local administration into the oral cavity","volume":"96","author":"Pistone","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_64","first-page":"807","article-title":"Artificial saliva and its use in biological experiments","volume":"68","author":"Jakubik","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/10837450.2019.1687520","article-title":"Assessment of taste masking of captopril by ion-exchange resins using electronic gustatory system","volume":"25","author":"Chikukwa","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Wasilewska, K., Szekalska, M., Ciosek-Skibinska, P., Lenik, J., Basa, A., Jacyna, J., Markuszewski, M., and Winnicka, K. (2019). Ethylcellulose in organic solution or aqueous dispersion form in designing taste-masked microparticles by the spray drying technique with a model bitter drug: Rupatadine fumarate. Polymers, 11.","DOI":"10.3390\/polym11030522"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/j.1552-4604.1991.tb01906.x","article-title":"Pharmacokinetics and oral bioavailability of hydrocortisone","volume":"31","author":"Derendorf","year":"1991","journal-title":"J. Clin. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.metabol.2017.02.005","article-title":"Pharmacokinetics of oral hydrocortisone\u2014Results and implications from a randomized controlled trial","volume":"71","author":"Buning","year":"2017","journal-title":"Metabolism"},{"key":"ref_69","first-page":"001","article-title":"Bioavailability of oral hydrocortisone corrected for binding proteins and measured by LC-MS\/MS using serum cortisol and salivary cortisone","volume":"10","author":"Johnson","year":"2018","journal-title":"J. Bioequivalence Bioavailab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1208\/s12249-018-1090-4","article-title":"Co-processed excipients for dispersible tablets\u2014Part 1: Manufacturability","volume":"19","author":"Bowles","year":"2018","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"ref_71","first-page":"380","article-title":"Superdisintegrants in fast disintegrating drug delivery systems: A brief review","volume":"3","author":"Vimal","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_72","unstructured":"(2024, May 19). STEP Database. Available online: https:\/\/step-db.ucl.ac.uk\/eupfi\/appDirectLink.do?appFlag=login."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.2174\/1381612823666170926122613","article-title":"Age-appropriate formulations including pharmaceutical excipients in neonatal medicines","volume":"23","author":"Kogermann","year":"2018","journal-title":"CPD"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.xphs.2017.12.002","article-title":"Understanding the factors that control the quality of mini-tablet compression: Flow, particle size, and tooling dimension","volume":"107","author":"Zhao","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"ref_75","unstructured":"FDA, CDER (2024, May 19). Guidance for industry\u2014Orally disintegrating tablets, Available online: https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070578.pdf."},{"key":"ref_76","first-page":"1635","article-title":"A stable hydrocortisone nanosuspension for improved dissolution: Preparation, characterization and in vitro evaluation","volume":"30","author":"Ali","year":"2017","journal-title":"Pak. J. Pharm. Sci."},{"key":"ref_77","unstructured":"Pubchem (2024, May 19). Hydrocortisone Melting Point, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Hydrocortisone."},{"key":"ref_78","unstructured":"Pubchem (2024, May 19). Mannitol Melting Point, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Mannitol#section=Boiling-Point."},{"key":"ref_79","unstructured":"Pubchem (2024, May 19). Magnesium Stearate Melting Point, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Magnesium-Stearate."},{"key":"ref_80","first-page":"1","article-title":"Spectral analysis of hydrocortisone","volume":"2","author":"Manivannan","year":"2009","journal-title":"J. Chem. Pharm. Sci."},{"key":"ref_81","unstructured":"(2024, May 19). European Medicines Agency (EMA): Guidelines on the Investigation of Bioequivalence, London 2010. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-investigation-bioequivalence-rev1_en.pdf."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/8\/1041\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:29:57Z","timestamp":1760110197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/8\/1041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,4]]},"references-count":81,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["pharmaceutics16081041"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16081041","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,4]]}}}